Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Terns Pharmaceuticals, Inc. | Chief Executive Officer, Director | Common Stock | 9.77K | $36.9K | $3.78 | May 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TERN | Terns Pharmaceuticals, Inc. | May 31, 2023 | 1 | $2.98K | 4 | Jun 2, 2023 | Chief Executive Officer, Director |
TERN | Terns Pharmaceuticals, Inc. | Feb 1, 2023 | 2 | $4.23 | 4 | Feb 3, 2023 | Chief Executive Officer, Director |
TERN | Terns Pharmaceuticals, Inc. | May 31, 2022 | 1 | $11.3K | 4 | Jun 8, 2022 | Chief Executive Officer, Director |
TERN | Terns Pharmaceuticals, Inc. | Jan 26, 2022 | 1 | $0 | 4 | Jan 28, 2022 | Chief Executive Officer, Director |
TERN | Terns Pharmaceuticals, Inc. | Sep 28, 2021 | 1 | $0 | 4 | Sep 30, 2021 | Chief Executive Officer, Director |
AKLI | Social Capital Suvretta Holdings Corp. I | Sep 24, 2021 | 0 | $0 | 3 | Sep 24, 2021 | Director |